Jagsonpal Pharmaceuticals

quarterly
yearly
ParticularsSep '23Dec '23Mar '24Jun '24Sep '24
Revenue60.1049.7545.9862.8876.34
Expenses50.1444.4841.4452.4960.98
EBITDA10.645.925.1511.6817.94
EBIT10.185.514.767.3315.60
Profit Before Tax9.965.284.547.1115.37
Net Profit7.473.963.555.3311.46
Financial Ratios
Operating Profit Margin18.40%12.53%11.86%13.67%24.02%
Net Profit Margin12.92%8.38%8.16%12.68%15.34%
Earning Per Share (Diluted)2.841.471.311.934.25
Dividends Per Share0.000.000.000.000.00
ⓒ 2016-2024 Groww. All rights reserved, Built with in India
MOST POPULAR ON GROWWVERSION - 5.5.9
STOCK MARKET INDICES:  S&P BSE SENSEX |  S&P BSE 100 |  NIFTY 100 |  NIFTY 50 |  NIFTY MIDCAP 100 |  NIFTY BANK |  NIFTY NEXT 50
MUTUAL FUNDS COMPANIES:  GROWWMF |  SBI |  AXIS |  HDFC |  UTI |  NIPPON INDIA |  ICICI PRUDENTIAL |  TATA |  KOTAK |  DSP |  CANARA ROBECO |  SUNDARAM |  MIRAE ASSET |  IDFC |  FRANKLIN TEMPLETON |  PPFAS |  MOTILAL OSWAL |  INVESCO |  EDELWEISS |  ADITYA BIRLA SUN LIFE |  LIC |  HSBC |  NAVI |  QUANTUM |  UNION |  ITI |  MAHINDRA MANULIFE |  360 ONE |  BOI |  TAURUS |  JM FINANCIAL |  PGIM |  SHRIRAM |  BARODA BNP PARIBAS |  QUANT |  WHITEOAK CAPITAL |  TRUST |  SAMCO |  NJ